Invention Grant
US08715936B2 Method of determining types I, II, III, IV or V or methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample
有权
在生物样品中测定I,II,III,IV或V型或耐甲氧西林金黄色葡萄球菌(MRSA)的方法
- Patent Title: Method of determining types I, II, III, IV or V or methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample
- Patent Title (中): 在生物样品中测定I,II,III,IV或V型或耐甲氧西林金黄色葡萄球菌(MRSA)的方法
-
Application No.: US12930663Application Date: 2011-01-13
-
Publication No.: US08715936B2Publication Date: 2014-05-06
- Inventor: Scott E. Gygax , Christina Lim Overmyer , Lisa A. DeSalvia , Martin E. Adelson , Eli Mordechai
- Applicant: Scott E. Gygax , Christina Lim Overmyer , Lisa A. DeSalvia , Martin E. Adelson , Eli Mordechai
- Applicant Address: US NJ Hamilton
- Assignee: Medical Diagnostic Laboratories, LLC
- Current Assignee: Medical Diagnostic Laboratories, LLC
- Current Assignee Address: US NJ Hamilton
- Agent Siu K. Lo
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34 ; C07H21/04

Abstract:
Disclosed are diagnostic methods for determining a subtype of methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample of a mammal. Methods include providing a biological sample of the mammal, performing a PCR analysis of the biological sample, and analyzing the PCR amplicons with respect to their sizes so as to determine for type I, type II, type III, type IV or type V MRSA that may be present in the biological sample. Further example embodiments include using at least one mecA primer pair and/or using at least one Staphylococcus aureus nuc primer pair in the PCR analysis. Further disclosed are methods for screening populations for MRSA, and methods of treating a mammal testing positive for Type IV MRSA. Also disclosed are kits for determining a MRSA subtype in a mammal and isolated primers that may be used in the present methods and kits.
Public/Granted literature
Information query